ALLTAQ
Live / Registered — Cancelled — Section 71 (as of 16 Jan 2026)
What this means for you
Registered since 02 Jul 2019. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79227907
- Registration number
- 5790162
- Mark type
- Stylized text
- Filed
- 13 Oct 2017
- Published for opposition
- 13 Nov 2018
- Registered
- 02 Jul 2019
- Attorney of record
- Randolph E. Digges, III
Goods and services
- Class 001 — Chemicals: Chemical, biochemical and biotechnological diagnostic preparations used in science, non-medical reagents, enzymes and chemicals, namely, buffer solutions used in analytical chemistry, for scientific and/or medical research use for marking, separating, isolating, purifying, amplifying, cloning, sequencing and/or for the analysis of biopolymers, in particular nucleic acids, in particular reagents, enzymes and buffer solutions for nucleic acid amplification and cloning; chemical test kits for laboratory or research use for marking, separating, isolating, purifying, amplifying, cloning, sequencing and/or for the analysis of biopolymers, in particular nucleic acids, in particular comprising reagents, enzymes and buffer solutions for nucleic acid amplification and cloning
- Class 005 — Pharmaceuticals: Diagnostic preparations for medical purposes; diagnostic preparations for veterinary purposes; diagnostic preparations for humans for medical purposes; Diagnostic preparations for medical and veterinary purposes, namely, diagnostics preparations for marking, separating, isolating, purifying, amplifying, cloning, sequencing and/or for the analysis of biopolymers, namely, nucleic acids; diagnostic reagents, enzymes and buffer solutions for nucleic acid amplification and cloning for medical or veterinary purposes; chemical, biochemical and biotechnological diagnostic preparations for medical and veterinary purposes, namely, reagents, enzymes and buffer solutions for marking, separating, isolating, purifying, amplifying, cloning, sequencing and/or for the analysis of biopolymers, namely, nucleic acids; Diagnostic kits containing preparations for medical and veterinary diagnostic purposes, namely, for marking, separating, isolating, purifying, amplifying, cloning, sequencing and/or for the analysis of biopolymers, namely, nucleic acids; Diagnostic kits containing reagents, enzymes and buffer solutions for nucleic acid amplification and cloning for medical or veterinary purposes
Owner
- Qiagen GmbH, DE
- Qiagen GmbH, DE
- Qiagen GmbH, DE
Prosecution history
- 16 Sept 2026 — TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
- 16 Jan 2026 — CANCELLED SECTION 71
- 02 Jul 2024 — COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
- 05 Dec 2020 — FINAL DECISION TRANSACTION PROCESSED BY IB
- 13 Mar 2020 — LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED
- 24 Jan 2020 — LIMITATION OF GOODS RECEIVED FROM IB
- 20 Dec 2019 — REFUSAL PROCESSED BY IB
- 08 Nov 2019 — FINAL DECISION TRANSACTION PROCESSED BY IB
- 19 Oct 2019 — FINAL DISPOSITION NOTICE SENT TO IB
- 19 Oct 2019 — FINAL DISPOSITION PROCESSED
- 02 Oct 2019 — FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
- 02 Jul 2019 — REGISTERED-PRINCIPAL REGISTER
- 17 Jun 2019 — LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED
- 23 May 2019 — EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
- 14 May 2019 — TEAS CHANGE OF CORRESPONDENCE RECEIVED